Cargando…

Circulating angiogenic cells in glioblastoma: toward defining crucial functional differences in CAC-induced neoplastic versus reactive neovascularization

BACKGROUND: In order to identify suitable therapeutic targets for glioma anti-angiogenic therapy, the process of neovascularization mediated by circulating angiogenic cells (CACs) needs to be scrutinized. METHODS: In the present study, we compared the expression of neovascularization-related genes b...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huizer, Karin, Sacchetti, Andrea, Swagemakers, Sigrid, van der Spek, Peter J, Dik, Wim, Mustafa, Dana A, Kros, Johan M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Basic and Translational Investigations
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7276933/ https://www.ncbi.nlm.nih.gov/pubmed/32642695 http://dx.doi.org/10.1093/noajnl/vdaa040

Ejemplares similares

Circulating Proangiogenic Cells and Proteins in Patients with Glioma and Acute Myocardial Infarction: Differences in Neovascularization between Neoplasia and Tissue Regeneration
por: Huizer, Karin, et al.
Publicado: (2019)

Brain radiotoxicity-related 15CAcBRT gene expression signature predicts survival prognosis of glioblastoma patients
por: Reyes-González, Jesús, et al.
Publicado: (2022)

GBMdeconvoluteR accurately infers proportions of neoplastic and immune cell populations from bulk glioblastoma transcriptomics data
por: Ajaib, Shoaib, et al.
Publicado: (2023)

Multiomics profiling of paired primary and recurrent glioblastoma patient tissues
por: Dekker, Lennard J M, et al.
Publicado: (2020)

Cannabidiol converts NF-κB into a tumor suppressor in glioblastoma with defined antioxidative properties
por: Volmar, Marie N M, et al.
Publicado: (2021)

Defining EGFR amplification status for clinical trial inclusion
por: French, Pim J, et al.
Publicado: (2019)

Near haploidization is a genomic hallmark which defines a molecular subgroup of giant cell glioblastoma
por: Baker, Tiffany G, et al.
Publicado: (2020)

Effects of valproic acid on histone deacetylase inhibition in vitro and in glioblastoma patient samples
por: Berendsen, Sharon, et al.
Publicado: (2019)

The EGFRvIII transcriptome in glioblastoma: A meta-omics analysis
por: Hoogstrate, Youri, et al.
Publicado: (2021)

Multireceptor targeting of glioblastoma
por: Sharma, Puja, et al.
Publicado: (2020)

RNU6-1 in circulating exosomes differentiates GBM from non-neoplastic brain lesions and PCNSL but not from brain metastases
por: Puigdelloses, Montserrat, et al.
Publicado: (2020)

Surgical resection of glioblastomas induces pleiotrophin-mediated self-renewal of glioblastoma stem cells in recurrent tumors
por: Knudsen, Arnon Møldrup, et al.
Publicado: (2021)

Metabolic alterations due to IDH1 mutation in glioma: opening for therapeutic opportunities?
por: N Mustafa, Dana A, et al.
Publicado: (2014)

Genetic variations in EGF and EGFR and glioblastoma outcome
por: Sjöström, Sara, et al.
Publicado: (2010)

CRN2 enhances the invasiveness of glioblastoma cells
por: Ziemann, Anja, et al.
Publicado: (2013)

GammaTile® brachytherapy in the treatment of recurrent glioblastomas
por: Gessler, Dominic J, et al.
Publicado: (2021)

Expression of pluripotency-related genes in human glioblastoma
por: Rios, Álvaro Fabrício Lopes, et al.
Publicado: (2021)

On optimal temozolomide scheduling for slowly growing glioblastomas
por: Segura-Collar, Berta, et al.
Publicado: (2022)

Comprehensive molecular characterization of multifocal glioblastoma proves its monoclonal origin and reveals novel insights into clonal evolution and heterogeneity of glioblastomas
por: Abou-El-Ardat, Khalil, et al.
Publicado: (2017)

Improving the characterization of endothelial progenitor cell subsets by an optimized FACS protocol
por: Huizer, Karin, et al.
Publicado: (2017)

NCoR controls glioblastoma tumor cell characteristics
por: Heldring, Nina, et al.
Publicado: (2014)

Sprouty2 enhances the tumorigenic potential of glioblastoma cells
por: Park, Jong-Whi, et al.
Publicado: (2018)

Proteins inform survival-based differences in patients with glioblastoma
por: Stetson, L C, et al.
Publicado: (2020)

The invasive proteome of glioblastoma revealed by laser-capture microdissection
por: Daubon, Thomas, et al.
Publicado: (2019)

Molecular profiles and immunomodulatory activities of glioblastoma-derived exosomes
por: Azambuja, Juliana Hofstatter, et al.
Publicado: (2020)

Functional connectivity within glioblastoma impacts overall survival
por: Daniel, Andy G S, et al.
Publicado: (2020)

Identification of five important genes to predict glioblastoma subtypes
por: Tang, Yang, et al.
Publicado: (2021)

Targeting the TREM1-positive myeloid microenvironment in glioblastoma
por: Filippova, Natalia, et al.
Publicado: (2022)

Data-driven prioritization and preclinical evaluation of therapeutic targets in glioblastoma
por: Brahm, Cyrillo G, et al.
Publicado: (2020)

Radiogenomic modeling predicts survival-associated prognostic groups in glioblastoma
por: Nuechterlein, Nicholas, et al.
Publicado: (2021)

Targeting extracellular matrix remodeling sensitizes glioblastoma to ionizing radiation
por: Thakur, Varsha, et al.
Publicado: (2022)

Organotypic slice cultures of human glioblastoma reveal different susceptibilities to treatments
por: Merz, Felicitas, et al.
Publicado: (2013)

MicroRNA-93 acts as an “anti-inflammatory tumor suppressor” in glioblastoma
por: Hübner, Max, et al.
Publicado: (2020)

Sexually dimorphic impact of the iron-regulating gene, HFE, on survival in glioblastoma
por: Nesterova, Darya S, et al.
Publicado: (2020)

Combination MEK and mTOR inhibitor therapy is active in models of glioblastoma
por: Schreck, Karisa C, et al.
Publicado: (2020)

Real-time evaluation of glioblastoma growth in patient-specific zebrafish xenografts
por: Almstedt, Elin, et al.
Publicado: (2021)

TGF-β promotes microtube formation in glioblastoma through thrombospondin 1
por: Joseph, Justin V, et al.
Publicado: (2021)

Identification and functional prediction of mitochondrial complex III and IV mutations associated with glioblastoma
por: Lloyd, Rhiannon E., et al.
Publicado: (2015)

Intratumor DNA methylation heterogeneity in glioblastoma: implications for DNA methylation-based classification
por: Wenger, Anna, et al.
Publicado: (2019)

Increased epithelial membrane protein 2 expression in glioblastoma after treatment with bevacizumab
por: Patel, Kunal S, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_e1166uh66tlgkk41h5lkn93fm7